Atlas Trials

Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA)

Clinical trial NCT02730923 · UNKNOWN

Trial details

NCT number
NCT02730923
Sponsor
Centre Leon Berard
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Endometrial CarcinomaMetastatic CarcinomaHormone Receptor Positive Tumor
Start date
2016-04-01
Primary completion
2019-11-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.